ArticlePDF Available

Abstract and Figures

We analyzed the spread of the COVID-19 epidemic in 6 metropolitan regions with similar demographic characteristics, daytime commuting population and business activities: the New York metropolitan area, the Île-de-France region, the Greater London county, Bruxelles-Capital, the Community of Madrid and the Lombardy region. The highest mortality rates 30-days after the onset of the epidemic were recorded in New York (81.2 x 100,000) and Madrid (77.1 x 100,000). Lombardy mortality rate is below average (41.4 per 100,000), and it is the only situation in which the capital of the region (Milan) has not been heavily impacted by the epidemic wave. Our study analyzed the role played by containment measures and the positive contribution offered by the hospital care system.
Content may be subject to copyright.
The spread of COVID-19 in six western metropolitan
regions: a false myth on the excess of mortality in Lombardy
and the defense of the city of Milan
Carlo Signorelli1, Anna Odone1,2, Vincenza Gianfredi1,3, Eleonora Bossi1, Daria Bucci1, Aurea
Oradini-Alacreu1, Beatrice Frascella1, Michele Capraro1, Federica Chiappa1, Lorenzo Blandi4,
Fabio Ciceri2
1School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; 2 IRCCS Ospedale San Raffaele, Milan, Italy; 3 CAPHRI
Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands; 4 IRCCS Policlinico San Do-
nato, School of Public Health, University of Pavia, Pavia, Italy
Summary. We analyzed the spread of the COVID-19 epidemic in 6 metropolitan regions with similar demo-
graphic characteristics, daytime commuting population and business activities: the New York metropolitan
area, the Île-de-France region, the Greater London county, Bruxelles-Capital, the Community of Madrid and
the Lombardy region. e highest mortality rates 30-days after the onset of the epidemic were recorded in
New York (81.2 x 100,000) and Madrid (77.1 x 100,000). Lombardy mortality rate is below average (41.4 per
100,000), and it is the only situation in which the capital of the region (Milan) has not been heavily impacted
by the epidemic wave. Our study analyzed the role played by containment measures and the positive contribu-
tion offered by the hospital care system. (www.actabiomedica.it)
Key words: COVID-19, Mortality, Metropolitan regions, Hospital care system
Acta Biomed 2020; Vol. 91, N. 2: 23-30 DOI: 10.23750/abm.v91i2.9600 © Mattioli 1885
Original investigations/Commentaries
Introduction
As history taught us, many airborne transmitted
diseases - causing large epidemics - spread along trade
routes and had the most dramatic effects in large urban
areas in terms of infections, incidence and mortality.
As it happened during the Black Death, a centripetal
trend is even recurring nowadays (1), with the COV-
ID-19 pandemic that, as of the 14th of April 2020, has
surpassed 2 million notified cases (although these data
largely underestimate the real situation) and 120,000
confirmed deaths, affecting large metropolitan areas
for the most part (2). A precise track of the infection
spread, across different geographical areas, is compli-
cated by the globalization that, also, greatly improve
the risks posed by trade routes (3), people gathering
(4) and work activities (5).
erefore, it is not by chance that in industrialized
countries the diffusion of SARS-CoV-2 had a greater
effect in the areas surrounding large urban centers (6):
as London, Paris, New York, Madrid, Bruxelles and
Milan amongst others. All these cities share similar
characteristics and well-established commercial ex-
changes with China, where the virus dissemination
started between the end of 2019 and January 2020.
Preventive actions have changed from the past:
in addition to quarantine, health authorities took ad-
vantage from limitations of mobility (7), lockdown
measures, the establishment of “red zones” (8), con-
tact tracing (6), home fiduciary isolation (9) and the
availability of new technologies (10), together with an
adequate risk communication (11,12). ese measures
acquire a crucial importance considering the current
lack of treatment and vaccinations.
With respect to the past centuries, the healthcare
systems, and in particular hospitals with intensive care
capacity, played an important role in saving lives but
were also an important mean of infection dissemina-
C Signorelli, A Odone, V Gianfredi, et al.
24
tion (13), as it happened with the SARS epidemic
(14), and at the beginning of the COVID-19 epidemic
(15). e infection of patients and healthcare work-
ers in the hospitals of Codogno and Casalpusterlen-
go – which were the first sites in which cases of local
Italian transmission were confirmed (16) – showed
how COVID-19 has a high tendency of diffusion in
healthcare environments (hospitals) and residential
care (nursing homes), that incidentally host individu-
als that are frail and at high risk (of older age and/or
affected by chronic conditions).
is epidemiological study, conducted within the
School of Public Health of Vita-Salute San Raffaele
University, analyzes six geographical settings that in-
clude relevant metropolitan areas, and aims at evalu-
ating the diffusion of COVID-19 and its mortality, to
assess the reaction of healthcare systems, and lastly, to
estimate the dynamics spread of the epidemic and the
efficacy of the healthcare measures implemented.
Methods
For each included metropolitan area, we built a
profile which included administrative, demographic
and social characteristics (the latter was estimated
in terms of daytime commuting population). We re-
treived the number of available hospital beds, with a
focus on intensive care units, and the measures im-
plemented by health authorities to cope with the epi-
demic. With respect to COVID-19, we analyzed the
number of deaths and draw mortality curves, starting
with the day during which the first 3 deaths were de-
clared in each area. Furthermore, we analyzed mortal-
ity rate at the level of regional and metropolitan areas,
to evaluate centripetal trend of the epidemic. Finally,
we analyzed in details the case of Lombardy and in
particular the metropolitan area of Milan due to its
peculiar features, and because its mortality rates has
been considered to be abnormal (17). Additionally,
we examined the containment measures implemented
by the healthcare authorities to reduce the inter-hu-
man transmission. Moreover, we reported the number
of patients admitted, for COVID-19, to two Italian
National Institutes for Scientific Research (IRCCS),
since the beginning of the epidemic to date. Moreover,
we anonymously retrieved their residence.
Results
First, we describe the characteristics of the six
metropolitan areas in terms of demographic data, in-
crease in daytime population, and healthcare:
New York – We analyzed the metropolitan area
of New York City, with five boroughs (Manhattan, e
Bronx, Queens, Brooklyn and Staten Island), a popu-
lation of 8,388,748 and density of 10,715 people/km2
(18). Manhattan is the most densely populated, with
26,821.6 inhabitants/km2 (19), and an increase of day-
time population of 1,499,757 commuters (20). In New
York City there are 23,000 hospital beds (21) (2.74
per 1,000 inhabitants), which increased to 38,400
since to the COVID-19 epidemic (22) (4.57 per 1,000
residents, 67% increase). At the beginning of the epi-
demic, 2,449 intensive care beds were available in New
York City (23), and increased of 62% (total available
3,965) by 10th April 2020 (24). Table 1 shows mortality
data starting from the beginning of the epidemic (15th
March 2020) (25).
Bruxelles – e Bruxelles-Capital Region has a
population of 1,208,542 people and a population den-
Table 1. Cumulative mortality rate (x 100,000) in the six metropolitan areas analyzed
Area Population
x 1,000 Beginning of the
epidemic* Increase of beds in
intensive care units Number of
deaths Cumulative
mortality rate°
New York City 8,623 15th March 67.0% 7,429 81.2
Community of Madrid 6,662 06th March 115.6% 5,136 77.1
Bruxelles-Capital 1,209 11st March 40.0% 587 48.6
Lombardy (Milan) 10,088 23rd February 114.0% 4,178 41.4
Ile-de-France (Paris) 12,278 11st March 109.0% 3,040 26.9
Greater London 9,304 7th March 19.8% 2,193 23.0
*Considered as the day during which the first 3 deaths were recorded; °Considered the 30th day since the beginning of the epidemic
e spread of COVID-19 in six western metropolitan regions 25
sity of 7,489 people/km2 (26). e central area includes
the city of Bruxelles (181,726 inhabitants, and popula-
tion density of 5,570 people/km2) (27), and 324,000
people commute there every day, in addition to the city
residents and the European Commission visitors (28).
Bruxelles-Capital Region has an availability of 6.74
hospital beds per 1,000 population (29). In Belgium,
1,900 intensive care beds increased by 40% during the
epidemic (11th March 2020) (30).
Community of Madrid – e Community of
Madrid has 6,661,949 inhabitants and a population
density of 829.84 people/km2 (31,32). e metropoli-
tan area of Madrid has 3,266,126 inhabitants and a
population density of 5,265 people/km2, in addition
it receives around 345,000 workers daily and 27,000
turists (33). In 2017 the region had 20,458 hospital
beds (3.14 per 1,000 people), among public and pri-
vate structures (34). e 800 intensive care beds of the
region increased to 1,725 to treat patients affected by
COVID-19 (35). To cope with the high number of
patients during the epidemic, the Ifema field hospital
has been built, and it can accommodate 5,000 beds in
9 pavilions (35). On the 1st April 2020 the number of
hospitalized people in the region of Madrid reached
a peak value with 15,227 occupied hospital bed and
1,528 patients in intensive care units (35). On 1st of
April 2020, the Ifema hospital hosted 930 patients, 16
of which in intensive care beds. Table 1 shows mortal-
ity data starting from the beginning of the epidemic
(6th March 2020) (35).
Île-De-France (Paris region) – We analyzed
the region of Île-de-France, with 8 Département, a
total population of 12,278,210 (18% of metropoli-
tan France population) and a population density of
1,022.25 people/km2 (36). It includes the city of Paris,
divided into 20 arrondissement, with 2,148,271 inhab-
itants and a population density of 20,382 people/km2
(37), with a daytime increase in population of 570,000
people commuting from Île -de-France (38). Île-de-
France counts 5.94 hospital beds per 1,000 inhabitants
(2014 update). In 2018 the region had 1,275 intensive
care beds (471 in Paris (39)), that increased by 109%
to 1,390 (40) since the beginning of the epidemic. is
was achieved by increasing the 3,000 intensive care
beds that were already available in the region, which
is sustained by private healthcare hospitals by 23.4%
(39). Table 1 shows mortality data starting from the
beginning of the epidemic (11th March 2020) (41).
Greater London – e county of Greater Lon-
don has 8,899,375 and a population density of 5,671/
km2. Inner London forms the central part of Greater
London with 12 boroughs and the City of London; it
has 3 million residents (42) and a density of popula-
tion of 9,404/km2). e daytime population creases by
a million of commuters daily (42). In Greater London
there are 21,361 NHS hospital beds open overnight,
1,507 of which are reserved for intensive care (43). To
cope with the increase in patients due to the epidemic,
private hospitals signed an agreement to provide more
than 2,000 hospital beds, and 250 between operating
rooms and intensive care beds (44). Furthermore, the
“NHS Nightingale Hospital London” has been tem-
porarily set up in the ExCeL convention center. It
hosts 500 intensive care beds, but it can receive up to
4,000 patients (45). anks to this measure, the total
number of hospital beds increased by 12.9%, and the
number of intensive care beds increased by 49.8%. Ta-
ble 1 shows mortality data starting from the beginning
of the epidemic (7th March 2020) (46).
Lombardy (Milan Region) – e Lombardy
Region, with a population of 10,060,574 people and
a population density of 422 inhabitants per km2. e
central metropolitan area of Milan, which consists of
the city of Milan and other 133 municipalities, with a
total of 3,250,315 inhabitants and a population den-
sity of 2,063 inhabitants per km2 (47), in addition to
1,441,409 people that commute every day. e Lom-
bardy Region consists of several highly populated areas
in proximity to Milan (Bergamo, Brescia, Monza, etc).
e intensive care beds available were 723 at the onset
of the epidemic, which increased to a total of 1,547
beds reserved for patients affected by COVID-19 after
30 days. is resulted in an increment of 113.9%, and
it includes only 10 of the potential 500 additional beds
allocated in the Milano Fiera pavilions. Table 1 shows
mortality data (48) starting from the beginning of the
epidemic (23rd February) (49).
Figure 1 represents the epidemic progress in the
six areas via cumulative daily mortality rate. We de-
cided to put the analytic comparison at day 30 from
the beginning of the outbreak (when 3 deaths were
reported) , due to the different chronological develop-
C Signorelli, A Odone, V Gianfredi, et al.
26
ment in each zone: day 30 is the time at which we
calculated the mortality rates for each area (Table 1).
Since China issued the first warnings about the
COVID-19 outbreak, European and USA health au-
thorities planned new preventive measures in order to
avoid the spread of the virus. ese actions (as health
check- points in airports, quarantine for people arriv-
ing from Hubei region, contact tracing and isolation)
proved to be inefficient in the prevention of a mas-
sive implication of the major metropolitan areas of the
western world. Italy was the first European country
to declare endemic cases, and it was the first country
to report outbreaks in Lombardy and Veneto regions
(50). Table 2 describes the most relevant actions taken
by the Government from February 21st to April 4th
2020. Similar measures were also adopted by the local
Governments of the administrative areas analyzed in
this report. One of the measures implemented was the
increase in the number of hospital beds and intensive
care beds, as the normal hospital capacity was not able
to host the number of COVID-19 cases requiring hos-
pitalization.
As an example, we reported the cases of the Lom-
bardy region and Greater London areas – as these two
entities have similar healthcare systems – in which the
public health authorities arranged agreements with
private hospitals in order to face the increased demand
for healthcare assistance. Figure 2 shows the flatten-
Table 2. Health protection measures against COVID-19 in Lombardy Region, 21 February – 4 April 2020
Date Public Health Measures Authority
21 February 2020 Mandatory supervised quarantine for 14 days for all individuals who have come
into close contact with confirmed cases of disease;
Mandatory communication to the Health Department from anyone who has
entered Italy from high-risk of COVID-19 areas, followed by quarantine and active
surveillance.
Ministry of Health
23 February 2020 Red zones in 11 municipalities in Lombardy Region: adoption of an adequate and
proportionate containment and management measures in areas with >1 person
positive to COVID-19 with unknown source of transmission.
National Government
23 February 2020 Development of a toll-free number for population Lombardy Region
08 March 2020 Lock-down: avoid any movement of people except for motivated by proven work
needs or situations of necessity (health, food and assistance);
National Government
08 March 2020 • Suspension of deferred and non-urgent hospitalization and outpatient activities.
• Reorganization of hospital activities
• Establishment of the Unique Post-Hospital Regional Discharge Center aimed at
managing the patients’ discharge
Lombardy Region
09 March 2020 Public communication campaign on social network #fermiamoloinsieme Lombardy Region
11 March 2020 Suspension of all commercial activities non-indispensable for production. National Government
23 March 2020 • Special Care Continuity Units (USCA) aimed at home management of patients
with COVID-19 who do not require hospitalization
• Identication of accommodation facilities (hotels) for discharged patients with
domestic isolation problems
• Establishment of a telemedicine service for GPs and their patients
Lombardy Region
30 March 2020 Further identification of day-care structure to isolate asymptomatic or low
symptomatic subjects
Lombardy Region
4 April 2020 Use of face mask (or other supply) for the whole population Lombardy Region
Figure 1. Cumulative daily mortality rate in the six areas
e spread of COVID-19 in six western metropolitan regions 27
ing of the epidemic curve as a result of public health
interventions, with the increase of the hospital capac-
ity, variously needed, in all the different areas analyzed.
We decided to investigate further the Lombardy
case, as it was the first to be described in the press and
to be of great scientific interest for its alleged excess of
deaths (45). e crude fatality rate (number of deaths/
number of notified cases) is largely affected by the
number of the tests performed and its results are not
significant, so we analyzed the mortality rate (Table 1).
It showed that, besides the higher number of deaths
and the delay of the start of the epidemic in the dif-
ferent areas, the trend documented in the Lombardy
region is significantly lower than three areas with the
highest mortality (New York, Madrid and Bruxelles).
Lombardy region is slightly higher than Paris and
London, even though it has a wider surface area.
We believe that such trend recorded in the Lom-
bardy region – despite the earlier start of the epidemic
– is due to the fact that the metropolitan area of Milan
has never been heavily hit by the epidemic wave, as
clearly shown considering mortality rates in the prov-
inces of Lombardy ad surrounding regions (Figure 3)
(51). As an example, we took into account the domicile
of 1,058 COVID-19 patients admitted to two Nation-
al Institutes for Scientific Research (IRCCS), situated
just outside the areas in which the two outbreaks took
place, 50 kilometers outside of Milan (Figure 4). e
data shows that most of these patients came from areas
located between the cities involved by the first out-
breaks and the city of Milan. is suggest that these
two hospitals (as well as the others in the metropoli-
tan area of Milan) have not payed a role as multiplier
of SARS-CoV-2 infections as probably happened in
smaller-sized hospitals - as for instance hospitals of
Lodi and Codogno - in the first phase of the epidemic.
Possible bias
e six areas analyzed have similar economic
characteristics, healthcare standards and COVID-19
surveillance data collection procedures, which allowed
us to make a reliable comparison of data. e choice
of these areas followed administrative borders and
the availability of the disaggregated mortality data. If
only focusing on the metropolitan area of Milan (3.2
Figure 2. Epidemiological trend and public health measures (“flat-
tening” the curve)
Figure 4. Geographic distribution of COVID cases requiring ho-
spitalization in two major hospitals of Milan (IRCCS)
Figure 3. Cumulative mortality rate per 100,000 population in
the Provinces of four Regions of Northern Italy, last update 17th
April 2020
C Signorelli, A Odone, V Gianfredi, et al.
28
million inhabitants), mortality rates would have been
about 45% lower (data not shown); if a wider area in-
cluding only the provinces surrounding Milan (Mon-
za, Bergamo and Lodi) had been evaluated (area of
5.5 million inhabitants), the mortality rate would have
been comparable to the regional data (data not shown).
Our analysis considered daily COVID-19 mor-
tality rates derived by national surveillance statistics,
which are more reliable than infection notifications
(confirmed cases). Indeed, notified cases data are
largely lower compared to the reality, and highly vari-
able depending on different swab strategies and crite-
ria adopted in different regions (52). Although it can-
not be ruled out that a portion of the deaths caused
by COVID-19 went undiagnosed, we believe that this
possible bias, estimated at 17% (53), is similar in the
other five areas (as suggested by international press re-
ports) thereby it doesn’t greatly affect the final asser-
tion of our comparative study.
Conclusions
We analyzed the COVID-19 epidemic trend in
six areas, comparable from an economic, social and
healthcare perspective, using reliable indicators, such as
the cause of death. New York City (8.4mln. inh.) and
Madrid (6.6mln. inh.) are the two metropolitan areas
mostly affected by the epidemic, while the Lombardy
region (10mln. inh.) – the first western area affected by
the epidemic and, in theory, less prepared – recorded a
high number of deaths (over 10,000) but a mortality
rate lower than three out of the six regions considered,
and a cumulative mortality rate on the 30th day about
50% lower than New York City and the Community
of Madrid. One of the reasons contributing to these
results, as mentioned earlier, could be that the epidemic
has not yet hit the metropolitan area of Milan (3.2mln.
inh.), but only smaller cities including Bergamo (1mil.
inh.). Two factors could have contributed to the posi-
tive “defense” to the metropolitan area with the higher
population density and commercial trades: firstly, the
efficacy and the promptness (54) of containment and
mitigation measures which resulted in increasing phys-
ical distancing and then in a reduction people gather-
ings ; secondly the effectiveness and safety of care pro-
vided by hospitals treating COVID-19 cases (47,48)
(considering that hospitals were an important driving
force of the transmission of this epidemic worldwide).
An additional refers to the general increase of
hospital beds and intensive care beds that was achieved
in a short time in all the examined areas, which allowed
to face the emergency. In particular, the Lombardy Re-
gion (as also done by the Community of Madrid and
Ile-de-France) more than doubled the number of beds,
both ordinary hospital beds and for intensive care.
Finally, the two countries with a public healthcare
system (Italy and UK), which recorded mortality rates
below the average, arranged formal agreements with
the private healthcare system. is aspect might have
given an important contribution to the management of
the emergency. Although emergency treatments were
provided in all considered areas with the same mod-
els (apparently free of charge) in all six areas, the fact
that the two countries with a public healthcare sys-
tem achieved lower mortality rates could be due to the
hospital system efficacy combined with the activity of
territorial services. In conclusion, we can state that a
“Lombardy case” did not occur in terms of a specific
mortality excess; moreover, the rapid adaptation of the
hospital network has been able to cope with a massive
epidemic wave managing, to date, to limit its spread in
the area with the highest population density.
A more complete analysis can be carried out for a
longer follow up (45 or 60 days since the onset of the
epidemic) in which it will be possible to better analyze,
for all the six areas considered (and possibly others),
the medium-term effect of the containment measures,
the actions of primary health care, the ignition of fur-
ther epidemic outbreaks and the overall management
of the epidemic.
Conflict of interest: Each author declares that he or she has no
commercial associations (e.g. consultancies, stock ownership, equity
interest, patent/licensing arrangement etc.) that might pose a con-
flict of interest in connection with the submitted article
Funding: is paper is a preliminary activity among the EU Project
n. 101003562 “ree Rapid Diagnostic tests (Point-of-Care) for
COVID-19 Coronavirus, improving epidemic preparedness, and
foster public health and socio-economic benefits - CORONADX”
(Task 7.1) supported by the Europeam Commission (Horizon
2020, H2020-SC1-PHE-CORONAVIRUS-2020).
e spread of COVID-19 in six western metropolitan regions 29
References
1. Boerner L, Severgnini B. Il commercio è alleato dei vi-
rus, lo dice la storia. 2020; https://www.lavoce.info/ar-
chives/64259/lo-dice-la-storia-il-commercio-e-alleato-
dei-virus/. Accessed 13 April 2020.
2. World Health Organization. COVID-19 weekly surveil-
lance report. 2020; http://www.euro.who.int/en/health-
topics/health-emergencies/coronavirus-covid-19/weekly-
surveillance-report, 2020.
3. Sebastiani G. Il coronavirus ha viaggiato in autostrada?
2020; https://www.scienzainrete.it/articolo/coronavirus-
ha-viaggiato-autostrada/giovanni-sebastiani/2020-04-09.
Accessed 13 April 2020.
4. Gatto M, Bertuzzo E, Mari L, et al. Spread dynamics of the
covid-19 epidemic in Italy: effects of emergency contain-
ment measures. PNAS. 2020;in press.
5. Prem K, Liu Y, Russell TW, et al. e effect of control
strategies to reduce social mixing on outcomes of the COV-
ID-19 epidemic in Wuhan, China: a modelling study. Lan-
cet Public Health. 2020.
6. Wilder-Smith A, Chiew CJ, Lee VJ. Can we contain the
COVID-19 outbreak with the same measures as for SARS?
Lancet Infect Dis. 2020.
7. Kraemer MUG, Yang CH, Gutierrez B, et al. e effect of
human mobility and control measures on the COVID-19
epidemic in China. Science. 2020;in press.
8. Signorelli C, Scognamiglio T, Odone A. COVID-19 in
Italy: impact of containment measures and prevalence es-
timates of infection in the general population. Acta Biomed.
2020;91(3-S):175-179.
9. Tang B, Wang X, Li Q, et al. Estimation of the Transmis-
sion Risk of the 2019-nCoV and Its Implication for Public
Health Interventions. J Clin Med. 2020;9(2).
10. Mayor S. Covid-19: Researchers launch app to track spread
of symptoms in the UK. BMJ. 2020;368:m1263.
11. Gianfredi V, Odone A, Fiacchini D, Rosselli R, Battista T,
Signorelli C. Trust and reputation management, branding,
social media management nelle organizzazioni sanitarie:
sfide e opportunità per la comunità igienistica italiana. J
Prev Med Hyg. 2019;60(3):E108-E109.
12. Gianfredi V, Grisci C, Nucci D, Parisi V, Moretti M. [Com-
munication in health.]. Recenti Prog Med. 2018;109(7):374-
383.
13. Gan WH, Lim JW, Koh D. Preventing intra-hospital infec-
tion and transmission of COVID-19 in healthcare workers.
Saf Health Work. 2020;in press.
14. Lau JT, Fung KS, Wong TW, et al. SARS transmission
among hospital workers in Hong Kong. Emerg Infect Dis.
2004;10(2):280-286.
15. European Centre for Disease prevention and Control. Coro-
navirus disease 2019 (COVID-19) pandemic: increased trans-
mission in the EU/EEA and the UK – seventh update. Stock-
holm25 March 2020.
16. Cereda D, Tirani M, Rovida F, et al. e early phase of the
COVID-19 outbreak in Lombardy, Italy. Arvix. 2020;in press.
17. UCSC. Coronavirus, le stime dei ricercatori: “In Italia al-
meno 2800 morti non dichiarati”. 2020; https://www.
lastampa.it/topnews/primo-piano/2020/03/30/news/le-
stime-dei-ricercatori-almeno-2800-morti-non-dichiara-
ti-1.38653880. Accessed 13 April 2020.
18. United States Census. Explore Census Data. 2020; https://
data.census.gov/cedsci/. Accessed 13 April 2020.
19. United States Census. New York County (Manhattan Bor-
ough), New York. 2020; https://www.census.gov/quick-
facts/newyorkcountymanhattanboroughnewyork. Accessed
13 April 2020.
20. United States Census. Commuter-Adjusted Population
Estimates: ACS 2006-10. 2010; https://www.census.gov/
library/working-papers/2010/demo/mckenzie-01.html.
Accessed 13 April 2020.
21. New York State Department of Health. Hospitals by Region/
County and Service. 2020; https://profiles.health.ny.gov/
hospital/county_or_region/region:new+york+metro+-
+new+york+city. Accessed 13 April 2020.
22. Melby C, Gu J, Rojanasakul M. Mapping New York City
Hospital Beds as Coronavirus Cases Surge. 2020; https://
www.bloomberg.com/graphics/2020-new-york-coronavi-
rus-outbreak-how-many-hospital-beds/. Accessed 13 April
2020.
23. New York State Department of Health. Hospitals by Region/
County and Service. 2020; https://profiles.health.ny.gov/
hospital/county_or_region/region:new+york+metro+-
+new+york+city.
24. e City. Coronavirus in New York City. 2020; https://pro-
jects.thecity.nyc/2020_03_covid-19-tracker/. Accessed 13
April 2020.
25. NYC Health. COVID-19: Data. 2020; https://www1.nyc.gov/
site/doh/covid/covid-19-data.page. Accessed 15 April 2020.
26. European Commission. Population: Demographic situa-
tion, languages and religions. 2019; https://eacea.ec.europa.
eu/national-policies/eurydice/content/population-demo-
graphic-situation-languages-and-religions-7_en. Accessed
13 April 2020.
27. City population. Bruxelles Municipality. 2019; https://
www.citypopulation.de/en/belgium/bruxelles/_/21004__
bruxelles/. Accessed 13 April 2020.
28. Brussels Institute for Statistics and Analysis. Key figures for
the Brussels-Capital Region. 2017; http://statistics.brus-
sels/figures/key-figures-for-the-region#.XpScEcgzZPZ.
Accessed 13 April 2020.
29. Federal Public Service. e geographical distribution of ac-
credited hospital beds. 2020; https://www.healthybelgium.
be/en/key-data-in-healthcare/general-hospitals/organisa-
tion-of-the-hospital-landscape/categorisation-of-hospital-
activities/the-geographical-distribution-of-accredited-hos-
pital-beds. Accessed 13 April 2020.
30. Sciensano. COVID-19 - Situation épidémiologique. 2020;
https://epistat.wiv-isp.be/covid/. Accessed 15 April 2020.
31. Portal del Ayuntamiento de Madrid. Portal web del Ayun-
tamiento de Madrid. 2019; https://www.madrid.es/portal/
site/munimadrid#. Accessed 13 April 2020.
C Signorelli, A Odone, V Gianfredi, et al.
30
32. Instituto Nacional de Estadistica. Demografía y población.
2019; https://www.ine.es/. Accessed 13 April 2020.
33. Instituto Nacional de Estadistica. Atlas de la movilidad
residencia-trabajo en Comunidad de Madrid 2017. 2017;
https://www.madrid.org/iestadis/fijas/estructu/general/ter-
ritorio/atlasmovilidad2017/02_caract_gnral.html. Accessed
13 April 2020.
34. Ministerio de Sanidad de España. Situación de COVID-19
en España. 2020; https://covid19.isciii.es/. Accessed 13
April 2020.
35. Ministerio de Sanidad de España. Situación de COVID-19
en España. 2020.
36. Institut National de la statistique et des études éeconom-
iques. e National Institute of Statistics and Economic
Studies collects, analyses and disseminates information on
the French economy and society. 2019; https://www.insee.
fr/en/accueil. Accessed 13 April 2020.
37. Institut National de la statistique et des études éeconom-
iques. e National Institute of Statistics and Economic
Studies collects, analyses and disseminates information on
the French economy and society. 2019; https://www.insee.
fr/en/accueil.
38. Institut National de la statistique et des études éeconom-
iques. Les mobilités dans le Bassin parisien à trois âges de
la vie : faire ses études, aller travailler, prendre sa retraite.
2019; https://www.insee.fr/fr/statistiques/4258068?sommai
re=4258113. Accessed 13 April 2020.
39. Ministère des Solidarités et de la Santé. Nombre de lits
de réanimation, de soins intensifs et de soins continus en
France, fin 2013 et 2018. 2020. Accessed 13 April 2020.
40. Agence régional de santé Ile-de-France (Siège). Coronavi-
rus (Covid-19) : La lutte contre l’épidémie en Île-de-France.
2020; https://www.iledefrance.ars.sante.fr/coronavirus-cov-
id-19-lars-ile-de-france-mobilisee. Accessed 13 April 2020.
41. Gouvernement France. COVID-19 en France. 2020; htt-
ps://www.gouvernement.fr/info-coronavirus/carte-et-don-
nees. Accessed 13 April 2020.
42. World Population Review. London Population 2020. 2020;
https://worldpopulationreview.com/world-cities/london-
population/. Accessed 15 April 2020.
43. NHS England. Bed Availability and Occupancy Data –
Overnight. 2020; https://www.england.nhs.uk/statistics/
statistical-work-areas/bed-availability-and-occupancy/bed-
data-overnight/. Accessed 15 April 2020.
44. Financial Times. NHS enlists all English private hospitals
to treat coronaviru. 2020; https://www.ft.com/content/c9a-
9be78-6b7b-11ea-89df-41bea055720b. Accessed 15 April
2020.
45. NHS England. New NHS nightingale hospital to fight
coronavirus. 2020; https://www.england.nhs.uk/2020/03/
new-nhs-nightingale-hospital-to-fight-coronavirus/. Ac-
cessed 15 April 2020.
46. NHS England. COVID-19 Daily Deaths. 2020; https://
www.england.nhs.uk/statistics/statistical-work-areas/cov-
id-19-daily-deaths/. Accessed 15 April 2020.
47. Istituto Nazionale di Statistica (ISTAT). Popolazione
residente al 1° gennaio. 2019; http://dati.istat.it/Index.
aspx?DataSetCode=DCIS_POPRES1. Accessed 13 April
2020.
48. Odone A, Delmonte D, Scognamiglio T, Signorelli C.
COVID-19 deaths in Lombardy. Lancet Public Health.
2020;published April 24, 2020.
49. Dipartimento della Protezione Civile. COVID-19 Italia-
Monitoraggio della situazione. 2020; http://www.protezi-
onecivile.gov.it/attivita-rischi/rischio-sanitario/emergenze/
coronavirus. Accessed 15 April 2020.
50. Ministero della Salute. Covid-19 - Situazione in Italia.
2020; http://www.salute.gov.it/portale/nuovocoronavirus/
dettaglioContenutiNuovoCoronavirus.jsp?area=nuovoCoro
navirus&id=5351&lingua=italiano&menu=vuoto. Accessed
13 April 2020.
51. Emilia-Romagna Region. Epidemia COVID-19. Aggiorna-
mento del 17 aprile 2020 sui dati del giorno precedente. 2020.
52. Romanò L, Pariani E, Biganzoli E, Castaldi S. e end of
lockdown what next ? Acta Biomedica. 2020;91(2).
53. Rajgor DD, Lee MH, Archuleta S, Bagdasarian N, Quek
SC. e many estimates of the COVID-19 case fatality rate.
Lancet Infect Dis. 2020.
54. Gianfredi V, Balzarini F, Gola M, et al. Leadership in Public
Health: Opportunities for Young Generations Within Sci-
entific Associations and the Experience of the “Academy of
Young Leaders”. Front Public Health. 2019;7:378.
Received: 17 April, 2020
Accepted: 23 April 2020
Correspondence:
Prof. Carlo Signorelli
Director of the School of Public Health, Vita-Salute San Raf-
faele University, Milan, Italy
E-mail: signorelli.carlo@hsr.it
... Następne szczepionki to Johnson&Johnson (11 marca 2021 r.) oraz Novavax (20 grudnia 2021 r.). Szczepionki te posiadały autoryzacje Europejskiej Agencji Leków i były dopuszczone do stosowania w krajach Unii Europejskiej [4,8,7,10,17,18]. ...
Article
Full-text available
The analysis of adverse vaccine events and other adverse events in Poland was performed using reports obtained from the collections kept by the National Institute of Public Health – National Institute of Hygiene in the period from 27.12.2020 to 28.02.2022 concerning the number of registered cases of Vaccine adverse event and Adverse medical events, taking into account their classification and characteristics. The analysis included registered VAEs and AMEs after COVID-19 vaccines authorized in European Union countries, i.e., Comirnaty (PfizerBioNTech), Spikevax (Moderna), Vaxzevria (AstraZeneca), and the Janssen COVID-19 Vaccine (. The analysis of the data in the NIZP-PZH reports shows that the benefits of COVID-19 vaccine still outweigh the risk of adverse reactions, including the rare life-threatening symptoms that may occur with all 4 vaccines.
... The European Union shows significant variability in COVID-19 responses. Countries such as Italy and Spain, which have older populations, were severely impacted early in the pandemic, highlighting the challenges faced by nations with vulnerable demographics [5]. In contrast, Germany's robust healthcare system and effective testing strategy enabled it to manage the virus efficiently, resulting in lower mortality rates during the initial waves [6]. ...
Article
Full-text available
This study offers an in-depth analysis of the COVID-19 pandemic’s trajectory in several member countries of the European Union (EU) in order to assess similarities in their crisis experiences. We also examine data from the United States to facilitate a larger comparison across continents. We introduce our new approach, which uses a spatiotemporal algorithm to identify five distinct and recurring phases that each country underwent at different times during the COVID-19 pandemic. These stages include: Comfort Period, characterized by minimal COVID-19 activity and limited impacts; Preventive Situation, demonstrating the implementation of proactive measures, with relatively low numbers of cases, deaths, and Intensive Care Unit (ICU) admissions; Worrying Situation, is defined by high levels of concern and preparation as deaths and cases begin to rise and reach substantial levels; Panic Situation, marked by a high number of deaths relative to the number of cases and a rise in ICU admissions, denoting a critical and alarming period of the pandemic; and finally, Epidemic Control Situation, distinguished by limited numbers of COVID-19 deaths despite a high number of new cases. By examining these phases, we identify the various waves of the pandemic, indicating periods where the health crisis had a significant impact. This comparative analysis highlights the time lags between countries as they transitioned through these different critical stages and navigated the waves of the COVID-19 pandemic.
... The European Union shows significant variability in COVID-19 responses. Countries like Italy and Spain, which have older populations, are severely impacted early in the pandemic, highlighting the challenges faced by nations with vulnerable demographics [5]. In contrast, Germany's robust healthcare system and effective testing strategy enable it to manage the virus efficiently, resulting in lower mortality rates during the initial waves [6]. ...
Preprint
Full-text available
This study offers an in-depth analysis of the COVID-19 pandemic’s trajectory in several member countries of the European Union (EU) to assess similarities in their crisis experiences. We also examine data from the United States to facilitate a larger comparison across continents. We introduce our new approach, which uses a spatio-temporal algorithm to identify five distinct and recurring phases that each country undergoes at different times during the pandemic. These stages include a Comfort Period characterized by minimal COVID-19 activity and limited impacts. The Preventive Situation demonstrates the implementation of proactive measures, with relatively low numbers of cases, deaths, and Intensive Care Unit (ICU) admissions. The Worrying Situation is defined by high levels of concern and preparation as deaths and cases begin to rise and reach substantial levels. The Panic Situation is marked by a high number of deaths relative to the number of cases and a rise in ICU admissions, denoting a critical and alarming period of the pandemic. Finally, the Epidemic Control Situation distinguishes itself by limiting COVID-19 deaths despite a high number of new cases. By examining these phases, we identify the various waves of the pandemic, indicating periods where the health crisis has a significant impact. This comparative analysis highlights the time lags between countries as they transition through these different critical stages and navigate the waves of COVID-19.
... Ongoing efforts in vaccine R&D are prominently focused on innovative technologies designed to enhance the effectiveness and resilience of evolving vaccine platforms. These advancements not only show potential in strengthening vaccine efficacy, but also hold promise for addressing organizational challenges that emerged during the pandemic (118)(119)(120). The introduction of novel technologies may provide solutions to logistical complexities, particularly in the management of the cold chain, while simultaneously enabling more efficient and widespread immunization campaigns. ...
Article
Introduction: The COVID-19 pandemic had a profound impact on vaccines' Research and Development, on vaccines' market, and on immunization programmes and policies. The need to promptly respond to the health emergency boostered resources' al-location and innovation, while new technologies were made available. Regulatory procedures were revised and expedited, and global production and distribution capacities significantly increased. Aim of this review is to outline the trajectory of research in vaccinology and vaccines' pipeline, highlighting major challenges and opportunities, and projecting future perspectives in vaccine preventables diseases' prevention and control. Study design: Narrative review. Methods: We comprehensively consulted key biomedical databases including "Medline" and "Embase", preprint platforms, including"MedRxiv" and "BioRxiv", clinical trial registries, selected grey literature sources and scientific reports. Further data and insights were collected from experts in the field. We first reflect on the impact that the COVID-19 had on vaccines' Research and Development, regulatory frameworks, and market, we then present updated figures of vaccines pipeline, by different technologies, comparatively highlighting advantages and disadvantages. We conclude summarizing future perspectives in vaccines' development and immunizations strategies, outlining key challenges, knowledge gaps and opportunities for prevention strategies. Results: COVID-19 vaccines' development has been largely supported by public funding. New technologies and expetited autho-rization and distribution processes allowed to control the pandemic, leading vaccines' market to grow exponentially. In the post-pandemic era investments in prevention are projected to decrease but advancements in technology offer great potential to future immunization strategies. As of 2023, the vaccine pipeline include almost 1,000 candidates, at different Research and Development phase, including innovative recombinant protein vaccines, nucleic acid vaccines and viral vector vaccines. Vaccines' technology platforms development varies by disease. Overall, vaccinology is progressing towards increasingly safe and effective products that are easily manufacturable and swiftly convertible. Conclusions: Vaccine research is rapidly evolving, emerging technologies and new immunization models offer public health new tools and large potential to fight vaccines preventables diseases, with promising new platforms and broadened target populations. Real-life data analysis and operational research is needed to evaluate how such potential is exploited in public health practice to improve population health.
... On one hand, medical misinformation causes a significant health toll around the world, contributing to the use of unproven treatments, nonadherence to mitigation measures, and a high level of vaccine hesitancy [6,7]. During the pandemic, people were overwhelmed by different sources of information, especially by social media [8], while different health recommendations and policy responses to SARS-CoV-2 were set across the world [9][10][11]. On the other hand, social media users tend to confine their attention to a limited number of virtual spaces, thus determining a sharp community structure among news outlets and exposing them only to similar opinions [12,13]. ...
Article
Full-text available
An infodemic represents a concern for public health, influencing the general population’s perceptions of key health issues. Misinformation is rapidly spread by social media, particularly among young generations. We used data from the WHO “Social Media and COVID-19” study, which was conducted in 24 countries worldwide on over 23,000 subjects aged 18–40 years, to explore Generation Z and Millennials’ models for health-information-seeking behaviors on social media. We summarized data on the most used sources of information, content of interest, and content sharing, as well as the sentiment toward the infodemic, through descriptive statistics and Chi-square test to verify the differences between groups. Among the survey respondents, 9475 (40.3%) were from high-income countries (HIC), 8000 (34.1%) from upper-middle-income countries (UMIC), and 6007 (25.6%) from lower-middle-income countries (LMIC). Social media were the most used sources of information to retrieve news on COVID-19 disease (about 79% in HIC, 87% in UMIC, and 90% in LIC) and the COVID-19 vaccine (about 78% in HIC and about 88% in UMIC and LIC). More than a half of the young respondents declared that they pay attention to scientific contents (about 51% in HIC, 59% in UMIC, and 55% in LMIC). Finally, most young participants reported feeling overwhelmed by the infodemic. However, this sentiment did not stop them from seeking information about COVID-19. Our findings highlight the importance of shaping public health interventions and campaigns on social media platforms and leveraging scientific contents. Public health authorities should work also on strategies to improve the digital literacy of the population as a driving force to empower them and achieve better health outcomes.
... Lombardy, the most populous region in Italy with about 10 million inhabitants, was the first area involved in the outbreak [3,4], followed by other areas of Europe [5,6]. ...
Article
Full-text available
Objectives: The COVID-19 pandemic had a significant impact on emergency medical systems (EMS). Regarding the ST-elevation myocardial infarction (STEMI) dependent time network, however, there is little evidence linked to the post-pandemic phase regarding this issue. Such information could prove to be of pivotal importance regarding STEMI clinical management, especially pre-hospital clinical protocols such as fibrinolysis. Methods: A retrospective observational cohort study of all STEMI rescues recorded in the Lombardy EMS registry from the 1st of January 2019 to the 30th of December 2021. Results: Regarding the number of STEMI diagnoses, March 2020 (first pandemic wave in Italy) saw a reduction compared to March 2019 (OR 0.76 [0.60–0.93], p = 0.011). The average time of the entire mission increased to 63.1 min in 2021, reaching 64.7 min in 2020, compared with 57.7 min in 2019. The number of HUBs for STEMI patients saw a reduction, falling from 52 HUBs in the pre-pandemic phase to 13 HUBs during the first wave. Conclusions: During the pandemic phase, there was an increase in the transportation times of STEMI patients from home to the hospital. Such changes did not alter the clinical approach in the out-of-hospital phase. Indeed, the implementation of fibrinolysis was not required.
Article
Full-text available
z COVID-19 olarak bilinen pandemi ile Mart 2020 tarihinden itibaren tüm dünya mücadele etmektedir. Covid-19 pandemisinin sosyal, siyasal, ekonomik ve psikolojik açıdan bireylere yansımaları da kaçınılmaz olmaktadır. Pandeminin tüm boyutları ile mücadelesi hükümetler, yerel yönetimler ve sivil toplum kuruluşları işbirliği içinde sürdürülmektedir. Çalışmada pandemi sürecinde etkin olan bu kurumlar arasından kentsel alanda vatandaşlarla iç içe olan yerel yönetimlerin çalışmaları incelemeye alınmıştır. Küresel ölçekteki bu soruna en hızlı en pratik çözümlerin yerel yönetimler tarafından getirilmesi beklenmektedir. Yerel yönetim denildiğinde akla ilk gelen nüfusun büyük bir kısmını barındıran belediyeler olmaktadır. Bu çalışmada cevabı aranan başlıca soru; Dünyada ve Türkiye'de büyükşehir belediyelerinin salgınla mücadele sürecinde hangi hizmetlerle destek verdikleri olmuştur. Çalışmanın konusu, COVID-19'un etkisinde kalan ülkelerde ve Türkiye'de bulunan 30 büyükşehir belediyesinin yapmış olduğu hizmetlerdir. Bu doğrultuda çalışmanın amacı, tüm dünyada etkisi hala devam eden salgınla mücadelede belediyeler tarafından sunulan hizmetlerin araştırılması ve büyükşehir belediyelerinin öneminin tartışılmasıdır. Betimletici metodun uygulandığı çalışmada ulaşılan başlıca sonuç, merkezi idarenin yetişemediği alanlarda hızlı etkinlik gösteren yerel yönetimlerin o boşluğu doldurduğudur. Türkiye'de belediyeler tarafından maske üretiminden, sosyal yardımlara, dijital araçlarla evde sosyal-kültürel faaliyetlere kadar yaratıcı hizmetlerin sunulduğu tespit edilmiştir.
Article
COVID-19 olarak bilinen pandemi ile, Mart 2020 tarihinden itibaren tüm dünya mücadele etmektedir. Covid-19 pandemisinin sosyal, siyasal, ekonomik ve psikolojik açıdan bireylere yansımaları da kaçınılmaz olmaktadır. Pandeminin tüm boyutları ile mücadelesi hükümetler, yerel yönetimler ve sivil toplum kuruluşları işbirliğiyle sürdürülmektedir. Dünya nüfusunun dağılımına bakıldığında çoğunluğun kentlerde yaşadığı görülmektedir. Bu yüzden kentsel alanda vatandaşlarla iç içe olan yerel yönetimlerin de bu salgınla mücadelede önemi artmaktadır. Küresel ölçekteki bu soruna en hızlı en pratik çözümlerin yerel yönetimler tarafından gerçekleştirilmesi beklenmektedir. Yerel yönetim denildiğinde akla ilk gelen nüfusun büyük bir kısmını barındıran belediyeler olmaktadır. Bu çalışmada cevabı aranan başlıca soru; Dünyada ve Türkiye’de büyükşehir belediyelerinin salgınla mücadele sürecinde hangi hizmetlerle destek verdikleri olmuştur. Çalışmanın konusu, COVID-19’un etkisinde kalan ülkelerdeki ve Türkiye’de bulunan 30 büyükşehir belediyesinin yapmış olduğu hizmetlerdir. Bu doğrultuda çalışmanın amacı, tüm dünyada etkisi hala devam eden salgınla mücadelede belediyeler tarafından sunulan hizmetlerin araştırılması ve belediyelerin öneminin tartışılmasıdır. Betimletici metodun uygulandığı çalışmada ulaşılan başlıca sonuç, merkezi idarenin yetişemediği alanlarda hızlı etki gösteren yerel yönetimlerin o boşluğu doldurduğudur. Türkiye’de belediyeler tarafından maske üretiminden, sosyal yardımlara, dijital araçlarla evde sosyal-kültürel faaliyetlere kadar yaratıcı hizmetlerin sunulduğu tespit edilmiştir.
Article
This review aims to collect, analyse and synthesize the available evidence that can be provided by Wikipedia for epidemiologic surveillance purposes. PRISMA guidelines were followed. PubMed/Medline and Scopus were consulted. Out of 238 retrieved articles, 16 articles were included in the systematic review. The most frequently assessed infectious disease was Influenza, followed by arboviruses and measles. Influenza studies show that Wikipedia could be considered a scientifically valid surveillance system that fills the main gaps in existing traditional surveillance systems. As regards arboviruses, searches on the Web have positively mediated the relationship between epidemiological data and the number of Wikipedia page visualization. Regarding measles, studies showed a strong/moderate temporal correlation between infectious disease notification bulletins and Wikipedia search trends. Despite the type of infectious agents, three main aims can be detected: (i) understand the public’s interest, (ii) explore the use of Wikipedia by organizations, and (iii) assess the accuracy of Wikipedia content. These new strategies for surveillance of infectious diseases should be implemented, to date they could be useful in supporting traditional surveillance.
Chapter
We present a large-scale spatiotemporal analysis of excess mortality (EM) in the first COVID-19 epidemic wave in Lombardy and Veneto. Spatial statistics show that EM is spatially heterogenous in both regions. Global spatiotemporal correlation identifies EM trends that differ across regions during the epi-curve peak, but are uniform in early and late stages. Local spatiotemporal correlation identifies EM hotspots, coldspots, and transition zones. Identifying process dynamics and local features, spatiotemporal correlation can support epidemic surveillance.KeywordsSpatio-temporal diffusionBivariate Moran ICOVID-19 mortality
Article
Full-text available
52° Congresso NazionaleSocietà Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI)Perugia 16-19 ottobre 2019 Within the workshop: Le potenzialità delle azioni comunicative per la promozione e la tutela della salute pubblica
Article
Full-text available
Significance The ongoing pandemic of COVID-19 challenges globalized societies. Scientific and technological cross-fertilization yields broad availability of georeferenced epidemiological data and of modeling tools that aid decisions on emergency management. To this end, spatially explicit models of the COVID-19 epidemic that include e.g. regional individual mobilities, the progression of social distancing, and local capacity of medical infrastructure provide significant information. Data-tailored spatial resolutions that model the disease spread geography can include details of interventions at the proper geographical scale. Based on them, it is possible to quantify the effect of local containment measures (like diachronic spatial maps of averted hospitalizations) and the assessment of the spatial and temporal planning of the needs of emergency measures and medical infrastructure as a major contingency planning aid.
Article
Full-text available
Since the beginning of the COVID-19 epidemic in Italy, the Italian Government implemented several restrictive measures to contain the spread of the infection. Data shows that, among these measures, the lockdown implemented as of 9 March had a positive impact, in particular the central and southern regions of Italy, while other actions appeared to be less effective. When the true prevalence of a disease is unknown, it is possible estimate it, based on mortality data and the assumptive case-fatality rate of the disease. Given these assumptions, the estimated period-prevalence of COVID-19 in Italy varies from 0.35% in Sicity to 13.3% in Lombardy.
Article
Full-text available
Tracing infection from mobility data What sort of measures are required to contain the spread of severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19)? The rich data from the Open COVID-19 Data Working Group include the dates when people first reported symptoms, not just a positive test date. Using these data and real-time travel data from the internet services company Baidu, Kraemer et al. found that mobility statistics offered a precise record of the spread of SARS-CoV-2 among the cities of China at the start of 2020. The frequency of introductions from Wuhan were predictive of the size of the epidemic sparked in other provinces. However, once the virus had escaped Wuhan, strict local control measures such as social isolation and hygiene, rather than long-distance travel restrictions, played the largest part in controlling SARS-CoV-2 spread. Science , this issue p. 493
Article
Full-text available
Background In December, 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, emerged in Wuhan, China. Since then, the city of Wuhan has taken unprecedented measures in response to the outbreak, including extended school and workplace closures. We aimed to estimate the effects of physical distancing measures on the progression of the COVID-19 epidemic, hoping to provide some insights for the rest of the world. Methods To examine how changes in population mixing have affected outbreak progression in Wuhan, we used synthetic location-specific contact patterns in Wuhan and adapted these in the presence of school closures, extended workplace closures, and a reduction in mixing in the general community. Using these matrices and the latest estimates of the epidemiological parameters of the Wuhan outbreak, we simulated the ongoing trajectory of an outbreak in Wuhan using an age-structured susceptible-exposed-infected-removed (SEIR) model for several physical distancing measures. We fitted the latest estimates of epidemic parameters from a transmission model to data on local and internationally exported cases from Wuhan in an age-structured epidemic framework and investigated the age distribution of cases. We also simulated lifting of the control measures by allowing people to return to work in a phased-in way and looked at the effects of returning to work at different stages of the underlying outbreak (at the beginning of March or April). Findings Our projections show that physical distancing measures were most effective if the staggered return to work was at the beginning of April; this reduced the median number of infections by more than 92% (IQR 66–97) and 24% (13–90) in mid-2020 and end-2020, respectively. There are benefits to sustaining these measures until April in terms of delaying and reducing the height of the peak, median epidemic size at end-2020, and affording health-care systems more time to expand and respond. However, the modelled effects of physical distancing measures vary by the duration of infectiousness and the role school children have in the epidemic. Interpretation Restrictions on activities in Wuhan, if maintained until April, would probably help to delay the epidemic peak. Our projections suggest that premature and sudden lifting of interventions could lead to an earlier secondary peak, which could be flattened by relaxing the interventions gradually. However, there are limitations to our analysis, including large uncertainties around estimates of R0 and the duration of infectiousness. Funding Bill & Melinda Gates Foundation, National Institute for Health Research, Wellcome Trust, and Health Data Research UK.
Article
Full-text available
Coronavirus disease 2019 (COVID-19) poses an occupational health risk to healthcare workers. Several thousand healthcare workers have already been infected, mainly in China. Preventing intra-hospital transmission of the communicable disease is therefore a priority. Based on the Systems Engineering Initiative for Patient Safety model, the strategies and measures to protect healthcare workers in an acute tertiary hospital are described along the domains of work task, technologies and tools, work environmental factors, and organizational conditions. The principle of zero occupational infection remains an achievable goal that all healthcare systems need to strive for in the face of a potential pandemic.
Article
The Corona Virus 19 (COVID 19) epidemic is an infectious disease which was declared as a pandemic and hit all the Countries, all over the world, from the beginning of the year 2020. In Italy the epidemic is particular serious with 169.325 confirmed cases and 21.551 deaths on 20.04.2020. To stop the contagion on March 8 and up to May 3, the Italian Government decided a lockdown for all the Country, the authors suggest how to manage the reopening and restarting of all the activities avoiding a restart of the epidemic.